Cannabis Report
Home > Boards > US OTC > Biotechs >

PuraMed BioScience, Inc. (PMBS)

PMBS RSS Feed
Add PMBS Price Alert      Hide Sticky   Hide Intro
Moderator: wodehouse, rs99, skizimus
Search This Board: 
Last Post: 5/23/2018 7:37:28 AM - Followers: 299 - Board type: Free - Posts Today: 3



PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

http://finance.yahoo.com/news/puramed-bioscience-develops-cannabis-based-180000630.html


OTCPINK
PuraMed BioScience, Inc. is a U.S. SEC Registered & Reporting Company
http://www.otcmarkets.com/stock/pmbs/quote
PMBS

http://www.lipigesic.com/



Share Structure:
 As Of January 9th, 2015  O/S ? And Growing.

As Of January 9th 2015  4 Billion Shares Authorized (A/S)

40/1 Reverse Split in the Process which per company filings will result in Approximately 37 Million Shares Outstanding and Meet the OTCQB requi

About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic® M (for acute relief of migraine headaches), LipiGesic® H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience has completed a double blind placebo clinical trial for its leading product, LipiGesic® M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract 
LipiGesic® M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.


CLICK HERE to Read Lipigesic Clinical Trial 2011 Study

CLICK HERE to Read Lipigesic M  Double Blind 2013 Study
 

Products

Feverfew 3X, the main active ingredient in LipiGesic® M (for migraine relief), is an herb that has been recognized for centuries as having a beneficial effect on migraine, menstrual and other headaches. Another active ingredient, Ginger 2X, is anti-inflammatory, specifically suppressing the expression of several mediators felt crucial in migraine pathogenesis.
Read more: http://www.puramedbioscience.com/lipigesic-m/
 

A combination of acetylsalicylic acid (aspirin) and St. John’s Wort delivered utilizing our sublingual gel delivery system can dramatically increase the speed and levels of relief for many tension headache sufferers.
Read more: http://www.puramedbioscience.com/lipigesic-h/
 

Valerian, St. John’s Wort and Chamomile, all ingredients in LipiGesic® PM (for insomnia), have each been clinically demonstrated to promote healthy sleep. 
Read more: http://www.puramedbioscience.com/lipigesic-pm/

 




Where to Buy

New Distributors to be Announced soon!!!

 

 
 

Click Here to Buy Online:

 
http://www.amazon.com/PuraMed-BioScience-LipiGesic-Unit-Dispensers/dp/B00B4201PW
 
 


Recent News

   

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

 

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

"As we looked at the similarities between migraine and epilepsy the treatment path became obvious," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and migraine seem to be triggered by the same coritcal spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many migraineurs are prescribed epileptic medications."

According to an article in Seizure, the prevalence of migraine in people who experience epilepsy is 8.4 to 20 percent. In addition to migraine, an estimated 64 percent of epilepsy sufferers also experience seizure-related (ictal) headaches: 20 percent experience headache prior to the seizure (pre-ictal) and 44 percent experience headache after the seizure (post-ictal).

The third most common neurological disorder in the US, epilepsy affects approximately 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Epilepsy affects veterans wounded in combat. According to Citizens United to Cure Epilepsy, approximately 22 percent of the 440,000 military service men and women who experienced traumatic brain injury are expected to develop post-traumatic epilepsy.

"An epilepsy medication is a natural extension to our product line," said Mitchell. "We have developed a formula, now we will begin the setting up the trials. We have been approached by key researchers who have expressed interest in working with us on CBD-based products.

"Standardization is key to creating a quality sublingual formula," said Mitchell. " Sublingual delivery offers the distinct advantages of faster delivery and efficiency while avoiding the "first pass effect" that often degrades oral medications. Our goal is to build medicines that withstand scientific scrutiny and perform well in double-blind, placebo controlled clinical trials. We believe that the efficacy of our formulations will be proven by scientific trials. This type of testing lends credibility to our line of natural medications which often work faster, more effectively, and have fewer side effects than their chemical-based counterparts."

Currently, PuraMed BioScience is rebranding its flagship product, LipiGesic M, as MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this homeopathic, all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, is the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact: 
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO 
715-359-6373
rmitchell@PuramedBioScience.com 
www.PuramedBioScience.com

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M

 

SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure®  going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

"We've been working on this for over a year," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "We needed to secure the trademark for the name and create the image before we announced the development of the enhanced formula and our product line extensions. 

"The new name will be easier for people to remember and pronounce," said Mitchell. "We also believe the new look and color of the logo will convey our 'safe' and 'natural' message at a glance. Preliminary feedback about the change has been positive and we are pleased. We will now have packaging that reflects the excellent product inside."

PuraMed hopes to have the new product, which uses a flavor-enhanced version of the sublingual LipiGesic M formula, new packaging, new price point, and a new website ready for public purchase within the next two months, though promotion and distribution to retailers and targeted wholesale partners will begin earlier.

"The manufacturing order has been placed," said Mitchell. "Our marketing plan is being finalized and as soon as the packaging and the website are ready, we will launch."

MigraPure's fresh look and message will replace the red and yellow LipiGesic logo. A tagline that describes the product will also be a fundamental part of the logo.

"By using a tagline with the image, we can make a stronger statement and leave no doubt in the consumer's mind about what MigraPure is or what it does, which is also an improvement," said Mitchell. "During the re-launch, we will also reference LipiGesic M on the packaging and other marketing materials in order to maintain a connection with our clinical trial data and our current customer base."

Development of the gel, packaging, and launch of the website are the first steps in the rebranding effort. PuraMed plans to continue to sell LipiGesic M under the old label until the new product is available.

A version of the new logo can be seen at www.lipigesic.com/MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, are the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

SOURCE PuraMed BioScience, Inc.

Current LipiGesic M videos

  Dr. Cady videoDr. Roger Cady, discusses the results of treatment of migraine headache with fever few and ginger, the active ingredients in the migraine treatment LipiGesic® M.
VIEW NOW
  Sherry TorkosPharmacist Sherry Torkos recommends all-natural, homeopathic LipiGesic® M.
VIEW NOW
  Nutrition and J.J. Virgin fitness expert J.J. Virgin shares how LipiGesic® M has helped her teenage son eliminate migraine pain.
VIEW NOW

 

 

https://www.facebook.com/LipiGesicM
https://twitter.com/puramed
https://twitter.com/lipigesic

REBRANDING, TRADEMEARK AND PATENTS ARE NOW COMPLETE 07/30/2014
 

 

 

       

PMBS stuck @ .0001 again since February 2015!!
Will it ever break back above that again?? 



 

Cannabis Report
PMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#28605   This is from 3 and a half years wodehouse 05/23/18 07:37:28 AM
#28604   Ahh, if fishes were wishes...we've seen how this wodehouse 05/23/18 07:35:25 AM
#28603   Been lots of buying in PMBS over the Echo115 05/23/18 01:12:49 AM
#28602   You're walking in your sleep and dreaming if wodehouse 05/22/18 07:33:30 PM
#28601   Agreed. skizimus 05/22/18 07:30:49 PM
#28600   Form 0.00 bid illl take it buxcapital 05/22/18 02:33:51 PM
#28599   Wow $ 29.80 bid! Lol rs99 05/22/18 01:55:33 PM
#28597   I guess you haven’t been in a lot buxcapital 05/22/18 12:47:58 PM
#28596   Yeah right. Now 123,000,000+ on the ask right wodehouse 05/22/18 12:20:23 PM
#28595   LOW SHARE COUNT ON THE 2s THIS WILL buxcapital 05/22/18 11:35:17 AM
#28594   YESTERDAY .0002s where up as we’ll SOMETHINGS UP HERE!!! buxcapital 05/22/18 11:34:21 AM
#28593   Not anymore buxcapital 05/22/18 11:33:19 AM
#28592   Still no bid?? rs99 05/22/18 09:10:31 AM
#28591   .0002s up on the ask buxcapital 05/21/18 01:19:54 PM
#28590   yeah.....mmmmmhmmmm... and the last 6 months of hundreds skizimus 05/19/18 01:02:12 PM
#28589   Exactly right. Plus I have no idea what wodehouse 05/19/18 10:26:44 AM
#28588   Had you been around back then like some rs99 05/19/18 07:27:09 AM
#28587   Probably 1.4B?? Where did you come up Echo115 05/18/18 05:49:31 PM
#28586   Lol how would you know? Which SOS did rs99 05/18/18 05:31:25 PM
#28585   LOOKS LIKE THE OS IS VERY LOW FOR buxcapital 05/18/18 02:35:27 PM
#28583   Chart looking good.. Echo115 05/17/18 02:39:18 PM
#28582   That or trying to flip there 2’s on rs99 05/17/18 01:29:19 PM
#28581   Right now at 12:33, there is 118,618,204 on wodehouse 05/17/18 12:35:31 PM
#28580   Maybe in your Dreams. Anyone heard from the rs99 05/16/18 07:04:58 AM
#28578   Exactly right and soon many will be Echo115 05/14/18 12:16:29 PM
#28577   Looking good. Buying has been steadily increasing. Somebody skizimus 05/12/18 07:55:05 PM
#28576   Is this pretending to be surprised by this? skizimus 05/12/18 11:49:52 AM
#28575   Half a BILLION??? wodehouse 05/12/18 11:47:53 AM
#28574   Ive seen half a bil 2s scooped up skizimus 05/12/18 10:42:59 AM
#28573   Even that's still a long way from 158M Echo115 05/10/18 11:20:38 PM
#28572   Now 53,967,526. wodehouse 05/10/18 03:09:49 PM
#28571   There's not been 158M on the ask for Echo115 05/10/18 12:44:31 PM
#28570   Could be. I have on several occasions lately wodehouse 05/10/18 12:00:13 PM
#28569   Guess they are looking at after hours ask/ rs99 05/10/18 09:45:31 AM
#28568   Do not accuse me of a lie. wodehouse 05/10/18 07:00:06 AM
#28567   I use etrade and they are very reliable.. Echo115 05/10/18 02:45:36 AM
#28566   Go tell td ameritrade they have it all wodehouse 05/09/18 04:30:53 PM
#28565   There was never 158M on the ask.. Echo115 05/09/18 04:13:11 PM
#28564   158,000,000.00 @10.00 AM now 54,000,000. No bid. No wodehouse 05/09/18 03:33:34 PM
#28563   39,000,000.00 not 158,000,000.00 Echo115 05/09/18 02:34:58 PM
#28562   The truth is there is around 39,000,00 on Echo115 05/09/18 02:33:49 PM
#28561   158,000,000 on the ask, that's a lot of wodehouse 05/09/18 10:03:24 AM
#28560   Most will be left behind! Echo115 05/08/18 08:59:18 PM
#28559   This is simply a scare tactic by a Echo115 05/03/18 10:41:15 AM
#28558   Good luck WH. The buy volume tells the skizimus 05/02/18 09:48:01 PM
#28557   Everyone is selling this pos stock, there's your wodehouse 05/02/18 09:41:06 PM
#28556   https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140489098 skizimus 05/02/18 08:24:48 PM
#28555   Buying picks up? Now at .000001. What does wodehouse 05/02/18 08:06:22 PM
#28554   And now buying picks up like madness for skizimus 05/02/18 06:53:19 PM
#28553   Ok let's look, most of past year(s) no wodehouse 05/02/18 06:43:02 PM
PostSubject